Impact of Pre‐treatment Proteinuria Progression on the Risk of Increased Proteinuria During Ramucirumab Therapy
In addition to previously reported risk factors, aggravating proteinuria within six months before initiating RAM-based treatment appears to influence post-treatment proteinuria outcomes.
Authors
- Masahiko Kawai (ORCID: https://orcid.org/0000-0002-3347-5155)
- Ryosuke Ito (ORCID: https://orcid.org/0000-0001-6546-3696)
- Tomoyuki Hirashita
- Hiroyuki Ohno (ORCID: https://orcid.org/0000-0001-9716-3495)
- Shota Mano
- Haruka Nagase
- Kotoe Inoue
- Takahiro Hayashi (ORCID: https://orcid.org/0000-0002-9686-6903)
- Narutoshi Nagao
Institutions
- Kinjo Gakuin University (JP)
- Gifu Prefectural General Medical Center (JP)
Publication Details
- Journal
- Cancer Diagnosis & Prognosis
- Published
- 2025-07-01
- DOI
- https://doi.org/10.21873/cdp.10457
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00